Lotus Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
Lotus Pharmaceutical has a total shareholder equity of NT$17.3B and total debt of NT$11.3B, which brings its debt-to-equity ratio to 65.4%. Its total assets and total liabilities are NT$33.0B and NT$15.7B respectively. Lotus Pharmaceutical's EBIT is NT$5.1B making its interest coverage ratio 10.1. It has cash and short-term investments of NT$1.8B.
Key information
65.4%
Debt to equity ratio
NT$11.33b
Debt
Interest coverage ratio | 10.1x |
Cash | NT$1.77b |
Equity | NT$17.33b |
Total liabilities | NT$15.66b |
Total assets | NT$32.99b |
Recent financial health updates
Is Lotus Pharmaceutical (TWSE:1795) Using Too Much Debt?
Apr 24These 4 Measures Indicate That Lotus Pharmaceutical (TPE:1795) Is Using Debt Extensively
Apr 04Is Lotus Pharmaceutical (TPE:1795) Using Too Much Debt?
Dec 31Recent updates
Is Lotus Pharmaceutical (TWSE:1795) Using Too Much Debt?
Apr 24Benign Growth For Lotus Pharmaceutical Co., Ltd. (TWSE:1795) Underpins Its Share Price
Apr 09Lotus Pharmaceutical's (TWSE:1795) Solid Profits Have Weak Fundamentals
Mar 22These 4 Measures Indicate That Lotus Pharmaceutical (TPE:1795) Is Using Debt Extensively
Apr 04Lotus Pharmaceutical Co., Ltd.'s (TPE:1795) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Mar 09Did You Miss Lotus Pharmaceutical's (TPE:1795) 64% Share Price Gain?
Feb 11Should You Use Lotus Pharmaceutical's (TPE:1795) Statutory Earnings To Analyse It?
Jan 21Is Lotus Pharmaceutical (TPE:1795) Using Too Much Debt?
Dec 31I Ran A Stock Scan For Earnings Growth And Lotus Pharmaceutical (TPE:1795) Passed With Ease
Dec 10Lotus Pharmaceutical Co., Ltd. Just Missed EPS By 6.5%: Here's What Analysts Think Will Happen Next
Nov 19Financial Position Analysis
Short Term Liabilities: 1795's short term assets (NT$12.7B) exceed its short term liabilities (NT$4.5B).
Long Term Liabilities: 1795's short term assets (NT$12.7B) exceed its long term liabilities (NT$11.1B).
Debt to Equity History and Analysis
Debt Level: 1795's net debt to equity ratio (55.2%) is considered high.
Reducing Debt: 1795's debt to equity ratio has increased from 62.1% to 65.4% over the past 5 years.
Debt Coverage: 1795's debt is not well covered by operating cash flow (14.2%).
Interest Coverage: 1795's interest payments on its debt are well covered by EBIT (10.1x coverage).